A significant portion of current research and development efforts, higher federal healthcare funding, and a growing geriatric cancer incidence are some of the drivers propelling the global CINV existing and pipeline drugs market.Wilmington, Delaware, United States, July 18, 2023 (GLOBE NEWSWIRE) In 2021, the global CINV existing and pipeline drugs market was estimated to be worth US$ 1.9 billion. It is expected to increase at a 5.8% CAGR from 2022 to 2031. The global market for CINV existing